1. Home
  2. IDT vs KARD Comparison

IDT vs KARD Comparison

Compare IDT & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

N/A

Current Price

$77.30

Market Cap

1.5B

ML Signal

N/A

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$13.19

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IDT
KARD
Founded
1990
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
IDT
KARD
Price
$77.30
$13.19
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $41.00
AVG Volume (30 Days)
128.6K
★ 437.9K
Earning Date
12-03-2026
11-12-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
★ 14.95
N/A
EPS
★ 3.46
N/A
Revenue
★ $1,231,495,000.00
N/A
Revenue This Year
$2.39
N/A
Revenue Next Year
$0.75
$50.00
P/E Ratio
$22.47
★ N/A
Revenue Growth
★ 2.13
N/A
52 Week Low
$46.48
$12.23
52 Week High
$84.56
$27.00

Technical Indicators

Market Signals
Indicator
IDT
KARD
Relative Strength Index (RSI) 38.45 42.66
Support Level $51.16 $12.28
Resistance Level $84.48 $16.26
Average True Range (ATR) 2.14 1.26
MACD -0.86 -0.08
Stochastic Oscillator 14.00 14.03

Price Performance

Historical Comparison
IDT
KARD

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: